Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Knee Osteoarthritis (AMAZE 5)
Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Knee Osteoarthritis (AMAZE 5)
The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight and knee osteoarthritis. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
Key inclusion Criteria:
Exclusion Criteria:
clinicaltrials@novonordisk.com(+1) 866-867-7178
Chaïdári, Attica 12461, Greece
Athens, 115 27, Greece
Athens, 11525, Greece
Marousi, 15125, Greece
Thessaloniki, 54635, Greece
Naples, Campania 80131, Italy
Modena, Emilia-Romagna 41126, Italy
Udine, Friuli Venezia Giulia 33100, Italy
Milan, Lombardy 20149, Italy
San Donato Milanese, Lombardy 20097, Italy
Verona, Veneto 37126, Italy
Bialystok, Podlaskie Voivodeship 15-351, Poland
Bialystok, Podlaskie Voivodeship 15-351, Poland
Krakow, 31-826, Poland
Warsaw, 02-637, Poland
Warsaw, 02-637, Poland
Altındağ/Ankara, 06230, Turkey (Türkiye)
Bahçelievler/İstanbul, 34186, Turkey (Türkiye)
Çankaya/Ankara, 06800, Turkey (Türkiye)
Kepez/Çanakkale Merkez/Çanakkale, 17110, Turkey (Türkiye)
Merkez/Battalgazi/Malatya, 44280, Turkey (Türkiye)
Trabzon Merkez/Ortahisar/Trabzon, 61080, Turkey (Türkiye)
Yuregir/Adana, 01060, Turkey (Türkiye)